A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results
Matthew Winter(Weston Park Cancer Centre), Janet E. Brown(University of Sheffield), Sacha J. Howell(The Christie NHS Foundation Trust), Emma Rathbone(Calderdale and Huddersfield NHS Foundation Trust), Iain R. Macpherson(Beatson West of Scotland Cancer Centre), Jacqui Gath(Humber Teaching NHS Foundation Trust), Jessica Kendall(University of Leeds), Christine L. Taylor(National Institutes of Health), Richard Eastell(University of Sheffield), Sarah Brown(University of Leeds), Geraldine Murden(University of Leeds), Carlo Palmieri(University of Liverpool), Caroline Wilson(Weston Park Cancer Centre), Kash Purohit(Weston Park Cancer Centre), Rob Coleman(University of Sheffield), Chris Twelves(University of Leeds)
Cited by 10
Related Papers
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
|The Lancet|2011|1.1k
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial
|The Lancet|2009|837